Effects of single nucleotide polymorphisms in c-Myc on stable warfarin doses in patients with cardiac valve replacements
- 주제(키워드) 8q24 , c-Myc , transcription factor , VKORC1 , warfarin
- 등재 SCIE, SCOPUS
- 발행기관 FUTURE MEDICINE LTD
- 발행년도 2015
- 총서유형 Journal
- URI http://www.dcollection.net/handler/ewha/000000119519
- 본문언어 영어
- Published As http://dx.doi.org/10.2217/PGS.15.37
초록/요약
This study aimed to investigate an association between c-Myc SNPs and stable warfarin doses. Materials & methods: The influences of genetic polymorphisms on dose requirements were investigated by genotyping ten SNPs in 201 patients with stable warfarin doses; VKORC1 (rs9923231), CYP2C9 (rs1057910), CYP4F2 (rs2108622), GATA4 (rs10090884), c-Myc (rs4645962, rs4645943, rs4645948 and rs4645974) and 8q24 (rs1447295 and rs16901979). Results: Around 44.3% of the overall interindividual variability in warfarin dose requirements was explained by the multivariate regression model; VKORC1 genotype accounted for 26.4%, CYP2C9 genotype for 4.9%, age for 3.4%, c-Myc genotypes for 5.2% (rs4645974 for 2.4% and rs4645943 for 2.8%), CYP4F2 genotype for 2.9% and diuretic use for 1.5%. Conclusion: Our results revealed that c-Myc could be a determinant of stable warfarin doses.
more